Maxim Group Calls Tekmira Pharma (TKMR) News 'Ground Breaking'
Tweet Send to a Friend
Maxim Group analyst Jason Kolbert weighed in on Tekmira Pharma (NASDAQ: TKMR) after the company announced that the FDA has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE